125 related articles for article (PubMed ID: 12369969)
21. Α-aryl-N-alkyl nitrones, as potential agents for stroke treatment: synthesis, theoretical calculations, antioxidant, anti-inflammatory, neuroprotective, and brain-blood barrier permeability properties.
Chioua M; Sucunza D; Soriano E; Hadjipavlou-Litina D; Alcázar A; Ayuso I; Oset-Gasque MJ; González MP; Monjas L; Rodríguez-Franco MI; Marco-Contelles J; Samadi A
J Med Chem; 2012 Jan; 55(1):153-68. PubMed ID: 22126405
[TBL] [Abstract][Full Text] [Related]
22. CholesteroNitrones for Stroke.
Ayuso MI; Chioua M; Martínez-Alonso E; Soriano E; Montaner J; Masjuán J; Hadjipavlou-Litina DJ; Marco-Contelles J; Alcázar A
J Med Chem; 2015 Aug; 58(16):6704-9. PubMed ID: 26241908
[TBL] [Abstract][Full Text] [Related]
23. Radiation-activated prodrugs as hypoxia-selective cytotoxins: model studies with nitroarylmethyl quaternary salts.
Wilson WR; Tercel M; Anderson RF; Denny WA
Anticancer Drug Des; 1998 Sep; 13(6):663-85. PubMed ID: 9755724
[TBL] [Abstract][Full Text] [Related]
24. Novel N-oxide of naphthalimides as prodrug leads against hypoxic solid tumor: synthesis and biological evaluation.
Yin H; Xu Y; Qian X; Li Y; Liu J
Bioorg Med Chem Lett; 2007 Apr; 17(8):2166-70. PubMed ID: 17331719
[TBL] [Abstract][Full Text] [Related]
25. Hypoxia-selective antitumor agents. 7. Metal complexes of aliphatic mustards as a new class of hypoxia-selective cytotoxins. Synthesis and evaluation of cobalt(III) complexes of bidentate mustards.
Ware DC; Palmer BD; Wilson WR; Denny WA
J Med Chem; 1993 Jun; 36(13):1839-46. PubMed ID: 8515422
[TBL] [Abstract][Full Text] [Related]
26. Nitrone derivatives of trolox as neuroprotective agents.
Balogh GT; Vukics K; Könczöl A; Kis-Varga A; Gere A; Fischer J
Bioorg Med Chem Lett; 2005 Jun; 15(12):3012-5. PubMed ID: 15896960
[TBL] [Abstract][Full Text] [Related]
27. Novel 2-substituted nitronyl nitroxides as free radical scavengers: synthesis, biological evaluation and structure-activity relationship.
Wu Y; Bi L; Bi W; Li Z; Zhao M; Wang C; Ju J; Peng S
Bioorg Med Chem; 2006 Aug; 14(16):5711-20. PubMed ID: 16650996
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of a new family of glycolipidic nitrones as potential antioxidant drugs for neurodegenerative disorders.
Durand G; Polidori A; Salles JP; Pucci B
Bioorg Med Chem Lett; 2003 Mar; 13(5):859-62. PubMed ID: 12617908
[TBL] [Abstract][Full Text] [Related]
29. The semisynthetic spin-labelled derivatives of 3-hydroxybutanolide as potential oxidative stress inhibitors.
Liu Q; Liu ZL; Tian J; Shi W; Liu YQ
Nat Prod Res; 2014; 28(14):1037-44. PubMed ID: 24697680
[TBL] [Abstract][Full Text] [Related]
30. Antioxidant properties of newly synthesized N-propargylamine derivatives of nitroxyl: a comparison with deprenyl.
Kochman A; Skolimowski J; Gebicka L; Metodiewa D
Pol J Pharmacol; 2003; 55(3):389-400. PubMed ID: 14506318
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-cancer activity of 2,6-disubstituted N-methylpiperidine derivatives and their N-oxides.
Henderson ND; Plumb JA; Robins DJ; Workman P
Anticancer Drug Des; 1996 Sep; 11(6):421-38. PubMed ID: 8836108
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant and antiradical activities of resorcinarene tetranitroxides.
Vovk AI; Shivanyuk AM; Bugas RV; Muzychka OV; Melnyk AK
Bioorg Med Chem Lett; 2009 Mar; 19(5):1314-7. PubMed ID: 19208474
[TBL] [Abstract][Full Text] [Related]
33. 1, 2, 4-Triazine N-oxide derivatives: studies as potential hypoxic cytotoxins. Part II.
Cerecetto H; González M; Onetto S; Saenz P; Ezpeleta O; De Ceráin AL; Monge A
Arch Pharm (Weinheim); 2004 May; 337(5):247-58. PubMed ID: 15095418
[TBL] [Abstract][Full Text] [Related]
34. Hypoxia-selective antitumor agents. 6. 4-(Alkylamino)nitroquinolines: a new class of hypoxia-selective cytotoxins.
Denny WA; Atwell GJ; Roberts PB; Anderson RF; Boyd M; Lock CJ; Wilson WR
J Med Chem; 1992 Dec; 35(26):4832-41. PubMed ID: 1479583
[TBL] [Abstract][Full Text] [Related]
35. Structure-Based Design: Synthesis, X-ray Crystallography, and Biological Evaluation of N-Substituted-4-Hydroxy-2-Quinolone-3-Carboxamides as Potential Cytotoxic Agents.
Sabbah DA; Hishmah B; Sweidan K; Bardaweel S; AlDamen M; Zhong HA; Abu Khalaf R; Hasan Ibrahim A; Al-Qirim T; Abu Sheikha G; Mubarak MS
Anticancer Agents Med Chem; 2018; 18(2):263-276. PubMed ID: 28901259
[TBL] [Abstract][Full Text] [Related]
36. Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress.
Chavarría C; Perez DI; Pérez C; Morales Garcia JA; Alonso-Gil S; Pérez-Castillo A; Gil C; Souza JM; Porcal W
Eur J Med Chem; 2012 Dec; 58():44-9. PubMed ID: 23085773
[TBL] [Abstract][Full Text] [Related]
37. Design of anticancer prodrugs for reductive activation.
Chen Y; Hu L
Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
[TBL] [Abstract][Full Text] [Related]
38. The role of hypoxia-activated prodrugs in cancer therapy.
Denny WA
Lancet Oncol; 2000 Sep; 1(1):25-9. PubMed ID: 11905684
[TBL] [Abstract][Full Text] [Related]
39. [In vitro cytotoxicity of nitroxyl radicals with respect to tumor and diploid human cells and estimation of their antiviral activity].
Kiriliuk IA; sviatchenko VA; Morozov DA; Kazachinskaia EI; Kiselev NN; Bakunova SM; Voĭnov MA; Loktev VB; Grigor'ev IA
Antibiot Khimioter; 2012; 57(1-2):3-12. PubMed ID: 22741195
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of 1,2,5-oxadiazole N-oxide derivatives as hypoxia-selective cytotoxins.
Monge A; López de Ceráin A; Ezpeleta O; Cerecetto H; Dias E; Di Maio R; González M; Onetto S; Seoane G; Suescun L; Mariezcurrena R
Pharmazie; 1998 Nov; 53(11):758-64. PubMed ID: 9853357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
